Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their alliance with Infectious Disease Research Institute (IDRI) to accelerate the development of a Covid-19 vaccine candidate.
The results of the preclinical study, a collaboration between Tessa Therapeutics and Baylor College of Medicine, were presented at the 2019 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Washington, D.C.
The collaboration includes training and exchange of technical know-how in process development and formulation, filling knowledge gaps that exist from research and development to manufacturing